Home
Home
Brain Tumor Education
Brain Tumor Education
About GammaTile
About GammaTile
Clinical Trials
Clinical Trials
- Clinical Trials
- Clinical Trials FAQ
Contact
Contact
FOR PHYSICIANS
FIND A GAMMATILE CENTER

Contact
FOR PHYSICIANS
FIND A GAMMATILE CENTER

Home
Home
Brain Tumor Education
Brain Tumor Education
About GammaTile
About GammaTile
Clinical Trials
Clinical Trials
- Clinical Trials
- Clinical Trials FAQ

Error 404

The page you are looking for is not available.

GO TO HOMEPAGE

IMPORTANT SAFETY INFORMATION

GammaTile^® is indicated as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms. The potential for, and symptoms of, adverse events related to radiation exposure vary depending on the radiosensitivity of the exposed tissue, the amount of radiation delivered, and the placement of GammaTile(s). Serious side effects related to GammaTile Therapy are rare, and may include radiation brain changes including necrosis. GammaTile Therapy should not be used for patients with a known history of hypersensitivity to bovine-derived materials. Possible complications can occur with any neurosurgical procedure, including cerebrospinal fluid leaks, infection, delayed hemorrhage, and adhesion formation.

Instructions for Use
Terms of Use
Privacy Policy